Chronic non-infectious posterior uveitis: Dissecting real-world registry study of YUTIQ

This year, the COPHy meeting moves beyond retina, addressing uveitis, neuro-ophthalmology and glaucoma in Seville, Spain

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

The approval makes ILM-Blue the first DORC posterior dye product available in China, according to a press release from Zeiss

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

The synthetic opsin was packaged into an optimised AAV2 gene therapy vector that targets human retinal bipolar cells.

The partnership will use ocular imaging to build an AI foundation model and identify new genetic targets for degenerative diseases